| Date | Title | Description |
| 23.03.2026 | Finfinity Bags $2.4 Mn To Scale Digital Lending Marketplace | SUMMARY
Finfinity has raised $2.4 Mn (about ₹22.50 Cr) in its seed funding round led by the Mankind Pharma Promoter's Family Office
The startup operates a digital marketplace that helps buyers discover, compare, and access credit through re... |
| 18.03.2026 | Mankind Pharma acquires Roche’s Rivotril brand for India, bolsters CNS presence | - |
| 20.02.2026 | ChrysCapital inks $159 mn control deal for Novartis India, makes open offer | The Novartis logo at a building in Rotkreuz, Switzerland | Credit: Reuters/Arnd Wiegmann
Homegrown private equity firm ChrysCapital has agreed to acquire Swiss pharmaceutical major Novartis AG’s entire stake in its Mumbai-listed unit for Rs... |
| 03.02.2026 | Advent International to invest $305 mn in Aditya Birla Housing | Shweta Jalan, managing partner and head-India, Advent International
Private equity firm Advent International will invest Rs 2,750 crore (about $305 million) in Aditya Birla Housing Finance Ltd, the mortgage lending arm of Aditya Birla Capit... |
| 02.01.2026 | Cough syrup controversy: Segment sees a “cautious” shift by consumers and doctors, say industry -watchers | - |
| 13.08.2025 | Zepto secures Rs 400 Cr from Motilal Oswal Financial Services | Its raining money at Zepto, as the quick commerce unicorn closes a Rs 400 crore funding round from Motilal Oswal Financial Services.
"Acquisition is a part of the treasury investment book, executed with the objective of generating sust... |
| 13.08.2025 | Zepto Secures INR 400 Cr in Latest Funding Round from Motilal Oswal This new infusion comes months after the Aadit Palicha led company secured USD 350 million in November 2024 from Motilal Oswal's Pri... | Quick commerce unicorn Zepto has raised INR 400 crore in a fresh funding round from Motilal Oswal Financial Services, marking another significant step in its capital-raising spree.
In an exchange filing, Motilal Oswal stated, "Acquisit... |
| 01.07.2025 | Sun Pharma, Mankind, Cipla Lead Recruitments at SGT University's Mega Job Fest: PharmaPICK 2.0 | Gurugram, Haryana, India
SGT University, Gurugram, a NAAC A+ accredited institution renowned for its industry-aligned academics and placement-focused initiatives, successfully hosted PharmaPICK 2.0, A Mega Job Fest 2025, at its vibrant camp... |
| 14.05.2025 | The Evolving Landscape of Hospitality: A Closer Look at The Westin Resort & Spa Ubud and Chalet Hotels | The hospitality industry is a vibrant tapestry, woven with threads of culture, comfort, and commerce. Two recent narratives from this sector reveal contrasting tales of growth and challenge. The Westin Resort & Spa Ubud, Bali, invites t... |
| 14.05.2025 | Cedar Park's New Era: A Gateway to Growth and Opportunity | Cedar Park, Texas, is on the brink of transformation. The city is set to welcome two monumental projects: the Nebraska Furniture Mart (NFM) and a Marriott Hotel and Convention Center. These developments are not just buildings; they are the ... |
| 12.05.2025 | Chalet Hotels revenue jumps 21.3% in FY25 but profit drops on higher expenses and tax adjustments | Chalet Hotels Limited, backed by real estate company K Raheja Corp and owner of notable properties such as JW Marriott Mumbai, Sahar, and Westin Powai, reported strong revenue growth for FY25. However, net profit declined owing to higher op... |
| 03.04.2025 | No tariffs on Indian pharma; plays vital role in supplying affordable medicines to US | New Delhi, Apr 3 (PTI) The Trump administration has exempted the Indian pharma sector from reciprocal tariffs, recognising the vital role played by the domestic industry in supplying affordable medicines across the globe, including the US, ... |
| 20.03.2025 | Eli Lilly brings much-awaited weight-loss drug Mounjaro to India | The much-awaited weightloss and diabetes drug, Mounjaro from US-based Eli Lilly and Company will be available at local chemists in a few weeks, at an India-specific price.
Globally Mounjaro, and peers in this category, Ozempic/Wegovy from N... |
| 13.03.2025 | Generics Take Center Stage as Empagliflozin Patent Expires | The world of pharmaceuticals is often a battleground of innovation and competition. On March 11, 2025, the diabetes drug Empagliflozin, known commercially as Jardiance, stepped into a new era. The patent held by Boehringer Ingelheim (BI) ha... |
| 12.03.2025 | Day 1 after diabetes drug Empagliflozin goes off patent, generics go to town with it | Drugmakers have begun to roll-out their generic versions of diabetes drug Empagliflozin, on day one after the innovative blockbuster drug from Boehringer Ingelheim (BI) went off patent protection (March 11).
At least three domestic drugmake... |
| 28.02.2025 | Warburg, Kedaara, EY, Khaitan, Mankind Pharma among winners of VCCircle Awards 2025 | Winners of VCCircle Awards 2025
Private equity firms Warburg Pincus and Kedaara Capital, venture capital firm Blume Ventures, drugmaker Mankind Pharma and luggage maker Safari Industries are among the winners of the VCCircle Awards 2025.
No... |
| 20.02.2025 | VC-backed pet treat brand Dogsee Chews bags Series B funding | Dogsee Chew founders Sneh Sharma (left) and Bhupendra Khanal
Pet treat brand Dogsee Chew said Thursday it has secured $8 million (about Rs 69 crore) in a Series B round led by Ektha.com, a Hyderabad-based company which operates in real esta... |
| 20.02.2025 | Dogsee Chew Secures USD 8 Mn Series B Funding to Expand Global Presence With the fresh capital, Dogsee plans to expand its manufacturing capabilities by upgrading its current factories and building a ... | Bengaluru-based natural pet treat brand Dogsee Chew has raised USD 8 million in a Series B funding round led by Ektha.com, with participation from Shivanssh Holdings, Poddar Family Office, and existing promoters.
This brings the company's t... |
| 13.02.2025 | The New Frontier of Competition: India’s Regulatory Landscape for Private Equity | The world of private equity is changing. No longer can investors wade through deals without a care. The Competition Commission of India (CCI) is on high alert. Its focus? Common ownership in rival firms. This shift reflects a global trend. ... |
| 12.02.2025 | What the CCI's concerns over common ownership mean for private equity deals | Anisha Chand (left) and Yatharth V. Singh, Khaitan & Co
Gone are the days when private equity investments were considered entirely benign from an antitrust perspective. Over the last five years, the Competition Commission of India (CCI)... |
| 10.02.2025 | Chalet Hotels acquires Westin Spa in Uttarakhand from Mankind arm for ₹530 crore | Chalet Hotels Ltd has acquired The Westin Resort & Spa, Himalayas in Rishikesh as it expands its luxury footprint.
The company bought the 141-room luxury property in the foothills of Uttarakhand from Mahananda Spa and Resorts, a subsidi... |
| 29.01.2025 | Mankind Pharma, Gauri Khan, and Others Lead Innov8's INR 110 Cr Funding Round The funding issue was oversubscribed by 2.7 times and facilitated by InCred, with the company being valued at INR 1,000 cr... | Innov8, a leading provider of flexible workspaces and a subsidiary of OYO, has successfully raised INR 110 crore (approximately USD 13 million) in a primary funding round.
The round was led by prominent family offices, including Mankind Pha... |
| 08.01.2025 | Complete Circle Capital’s wealth management arm raises $3 million funding from Mankind Pharma promoters | Complete Circle Capital's wealth management division has secured $3 million in maiden fundraising round. The investment was led by Rajeev and Arjun Juneja of the Mankind Pharma Promoter Family Office, along with Narinder Bajaj, Chairman and... |
| 17.12.2024 | PE firm Advent to return a record ₹25,000 cr this year from India portfolio | Private equity firm Advent International will be returning around a record ₹25,000 crore this year to its limited partners (LPs) from gains on its India portfolio, aided by a couple of large ticket, profitable exits, sources said.
“That’s a... |
| 29.11.2024 | Zomato raises Rs 8,500 crore via QIP, Motilal Oswal emerges as biggest domestic investor | ETtechZomato CEO Deepinder Goyal
Food and grocery delivery major Zomato has raised Rs 8,500 crore through a qualified institutional placement (QIP) largely led by domestic investors, the company said on Friday.
Read More News on
Zomato fund... |
| 24.11.2024 | Zepto's Meteoric Rise: A $350 Million Leap into the Future of Quick Commerce | In the bustling world of quick commerce, Zepto has emerged as a shining star. The Mumbai-based startup recently secured a staggering $350 million in a funding round led by Motilal Oswal Private Wealth. This isn't just another funding story;... |
| 22.11.2024 | Zepto Secures USD 350 Mn Funding, Eyes IPO by 2026 The round was led by Motilal Oswal Private Wealth and also saw participation from investors, including Raamdeo Agarwal, the Taparia Family Office, Ma... | Mumbai-based quick commerce startup Zepto has raised USD 350 million in a funding round led by Motilal Oswal Private Wealth.
The round also saw participation from prominent investors, including Raamdeo Agarwal, the Taparia Family Office, Ma... |
| 22.11.2024 | Zepto raises additional $350M, its third funding round in 6 months as it expands rapidly
Recommended Stories For You | Quick commerce player Zepto has raised another $350 million in a funding round led exclusively by Motilal Oswal’s Private Wealth division, along with investment from Indian HNIs and family offices.
The round saw participation from Motilal O... |
| 22.11.2024 | Zepto mops up another $350 mn in an entirely domestic funding round | Zepto founders Kaivalya Vohra and Aadit Palicha
Quick commerce startup Zepto Friday said it has raised $350 million (around Rs 3,000 crore) in its latest fundraise from domestic investors, including HNIs, family offices, and leading financi... |
| 18.11.2024 | Ritesh Agarwal to increase shareholding in OYO with fresh infusion | Ritesh Agarwal, Founder and CEO of hospitality management platform OYO is set to invest an additional Rs 550 crore ($65.1 million approximately) into the company to increase his shareholding in the entity to 32%, from 30% held previously.... |
| 14.11.2024 | VC firm Pavestone raises Rs 816 Cr for technology fund | Pavestone, the Hyderabad-based growth stage venture capital firm has raised Rs 816 crore as the final close for its Pavestone Technology Fund.
Founded in 2021 by Sridhar Rampalli, Srikanth V J Tanikella, and Laxmikanth V, Pavestone had prev... |
| 08.11.2024 | Lupin aims to be part of ‘first wave of generics’ on GLP-1 products: Nilesh Gupta | Drugmaker Lupin aims to be part of the first wave of generic drugmakers to make GLP-1 receptor agonists products, used to treat Type II diabetes and obesity, Lupin top-brass said.
This segment of products includes semaglutide, the internati... |
| 22.10.2024 | The Age of Innovation: Bridging Generations in Tech | In the fast-paced world of technology, age is often seen as a double-edged sword. On one side, youth brings energy and adaptability. On the other, experience offers wisdom and depth. As the tech landscape evolves, the question arises: how i... |
| 21.10.2024 | The Empathetic Boss: Rajeev Juneja, MD and VC, Mankind Pharma Rajeev credits the company mantra of 'staying dynamic' as the reason behind its tremendous success over the years | Thirty-three years ago, the idea of Mankind Pharma became a reality with 20 employees and a seed capital of INR 5,000,000. Fast forward to 2024, it has a market capitalization of approximately INR 1.06 trillion and is the fourth-largest pha... |
| 21.10.2024 | Bridging Imagination and Innovation: SGT University Impresses again with a Grand Synergy 2024 | Gurugram, Haryana, India
Synergy, the grand tech-fest of SGT University that has become an annual landmark for the best in innovation and technology, concluded its 7th edition, Synergy 2024, with a grand valedictory ceremony that saw the be... |
| 25.09.2024 | Next Steps of Pharma Innovation: Affordable Meds, Addressing AMR, and India for World "Every fourth tablet consumed globally is made in India. We have come a long way in producing affordable, hig... | With India's healthcare market rapidly growing, the collaboration between the public and private sectors is essential to ensure healthcare is accessible, affordable, and of high quality, said Madhukar Kumar Bhagat, Joint Secretary, Union Mi... |
| 19.08.2024 | Advent International plans $300-400 m IPO of Manjushree Technopack | Advent International is looking at an initial public offering in the range $300-400 million for its portfolio company Manjushree Technopack with a valuation of $1.5-2 billion, sources said.
In 2018, the US-based global private equity firm h... |
| 14.08.2024 | Oyo raised nearly $175 M Series G funding from multiple investors | ASK Financial Holdings, InCred Wealth, Patient Capital, J&A Partners, the family office of Mankind Pharma promoters, and other investors contributed Rs 1,457 crore (about $175 million) to the hospitality giant Oyo in a Series G round.
A... |
| 14.08.2024 | Meitra Hospital Receives Swadesh Samman: Award for Excellence in Healthcare Innovation | New Delhi, Delhi, India
Meitra Hospital Calicut, a leading quaternary care hospital in Kerala, has won the Brand Bharat-Swadesh Samman award at Swadesh Conclave 2024. Meitra’s CEO Nihaj G Mohammed received the award from Nitin Gadkari, Mini... |
| 11.08.2024 | OYO's Funding Surge: A New Chapter in Hospitality | OYO, the hospitality giant, is back in the spotlight. It has successfully raised Rs 1,457 crore, roughly $175 million, in its latest funding round. This marks a significant moment for the company, which has faced its share of challenges in ... |
| 11.08.2024 | OYO raises Rs 1,457 Cr in latest funding round
Recommended Stories For You | Oravel Stays Ltd, the parent company of OYO, has raised Rs 1,457 crore from a consortium of investors in the latest funding round, sources said.
The IPO-bound unicorn has raised nearly Rs 1,040 crore in the Series G funding round. This fo... |
| 11.08.2024 | Oyo raises nearly $175 Mn in Series G round | Hospitality major Oyo has raised Rs 1,457 crore (nearly $175 million) in a Series G round from a group of investors including InCred Wealth, Patient Capital, J&A Partners, the family office of Mankind Pharma promoters and ASK Financial ... |
| 10.08.2024 | Swadesh Conclave 2024 Celebrates 'Brand Bharat' and Highlights New Media Revolution | New Delhi, Delhi, India
The 5th edition of Swadesh Conclave 2024, themed “Brand Bharat,” took place at Vigyan Bhawan on August 8, 2024, bringing together eminent leaders, visionaries, and cultural icons to honor and celebrate outstanding co... |
| 06.08.2024 | Sauce VC's Third Fund: A Recipe for Success | In the bustling world of venture capital, Sauce VC has stirred the pot once again. The firm recently announced the final close of its third fund, amassing a remarkable Rs 365 crore, or about $43.6 million. This achievement is not just a num... |
| 05.08.2024 | Sauce VC logs final close of third fund at Rs 365 crore | ETtechManu Chandra, founder and managing partner; Yash Dholakia, partner at Sauce VC
Consumer-focused venture investor Sauce VC has made the final close of its third fund at Rs 365 crore, against a target corpus of Rs 250 crore, said its fo... |
| 29.07.2024 | Bharat Serums and Vaccines would run as an independent business, says Mankind’s Rajeev Juneja | Days after Mankind Pharma inked a ₹13,630 crore deal to buy Bharat Serums and Vaccines (BSV), its top management said BSV would run as an independent business, reporting to the Mankind board.
BSV presented itself as an attractive opportunit... |
| 26.07.2024 | Mankind Pharma Acquires Bharat Serums and Vaccines for INR 13,630 Cr The biopharmaceutical company Bharat Serums was set up in 1971, with Vinod Daftary opening a blood bank and eventually launching an... | Mankind Pharma announced that it has entered into a definitive agreement to acquire a 100 percent stake in Bharat Serums and Vaccines (BSV) from private equity firm Advent International for an enterprise value of INR 13,630 crore.
"Thi... |
| 26.07.2024 | Mankind Pharma to buy Bharat Serums as Advent International exits | Credit: Reuters
Mankind Pharma Ltd has agreed to acquire Bharat Serums and Vaccines Ltd (BSV) from private equity firm Advent International for an enterprise value of about Rs 13,630 crore ($1.63 billion).
The move marks a "significant... |
| 26.07.2024 | Производитель презервативов Manforce купит поставщика товаров для женского здоровья за $1,6 млрд | Сделка предоставит Mankind, производителю презервативов Manforce и одной из крупнейших фармацевтических компаний Индии, доступ к продукции Bharat Serums, предназначенной для женского здоровья и лечения бесплодия.
«Мы считаем, что сегмент же... |
| 25.07.2024 | Mega sale of Advent-backed Bharat Serums: Mankind Pharma emerges as likely front-runner | Mumbai-based Bharat Serums and Vaccines Limited was set up in 1971 and is engaged in the development, manufacturing and marketing of biological, biotech and pharmaceutical formulations. |
| 25.07.2024 | Mankind Pharma to buy Bharat Serums from Advent for ₹13,630 cr | Mankind Pharma has clinched the deal to acquire Bharat Serums and Vaccines from private equity firm Advent International for ₹13,630 crore, the company said in a release.
The Delhi-based pharma firm said it has entered into a definitive agr... |
| 17.06.2024 | Hospitality chain OYO to raise Rs 1000 Cr at a valuation of $2.5B: Report | Hospitality startup OYOis in talks to raise a fresh round of funding of approximately Rs 1,000 crore ($120 million), primarily from the family offices of prominent Indian corporate executives and stock market experts, according to a repor... |
| 22.05.2024 | KKR, Blackstone in race for Advent-owned Bharat Serums & Vaccines: Report | The sale process for Bharat Serums & Vaccines Ltd, owned by private equity firm Advent International, has evinced interest from a bunch of global private equity funds including KKR, EQT, Blackstone, Bain Capital, Carlyle, Partners Group... |
| 16.05.2024 | M&M, Berger Paints, Mankind Pharma among six stocks to monitor on May 16 | - |
| 03.05.2024 | Delhi HC directs action against use of oxytocin in dairy colonies | - |
| 09.04.2024 | HDFC Bank Misses MSCI Threshold by a Hair's Breadth | HDFC Bank's foreign legroom inches close to the MSCI threshold but falls short by a mere 5 basis points, causing a ripple in the investment world. The potential for further selling this quarter could lead to a weight-up adjustment in the up... |
| 04.04.2024 | HDFC foreign legroom rises but misses index provider MSCI threshold | The investment legroom for foreign portfolio investors (FPIs) in HDFC Bank rose to 24.95 per cent during the quarter ended March 2024. However, it fell short by only 5 basis points (bps) of the threshold required for index provider MSCI to ... |
| 02.04.2024 | NSE halves lot size for trading derivatives contracts for Nifty50 index | The National Stock Exchange (NSE) on Tuesday said it has halved the lot size for trading derivatives contracts for the blue-chip Nifty 50 index to 25 and also reduced the lot sizes of the Nifty Financial Services and Nifty Midcap indices as... |
| 26.03.2024 | Recovery in exports amid rising chemical prices to drive SRF stock | Shares of SRF, the country’s largest specialty chemicals player, hit a 10-month high last week on expectations that recovery in exports, amid rising prices, could aid sales revival.
Given expectations of higher realisations across its main ... |
| 11.03.2024 | AstraZeneca, Mankind Pharma partner for distribution of asthma medication | In a move aimed at addressing the growing asthma burden in India, AstraZeneca Pharma India and Mankind Pharma on Monday announced that they are collaborating to exclusively distribute AstraZeneca's asthma medication, Symbicort (inhaler), in... |
| 05.01.2024 | Mankind Pharma Joins ONDC Network to Further Strengthen its Market Reach | New Delhi, Delhi, India
Mankind Pharma’s Consumer Health Division, a prominent player in India's health and wellness sector with brands like Manforce, Prega News, Gas-O-Fast, Health OK, and AcneStar has become a part of the Open Network for... |
| 19.04.2023 | Condom maker Mankind Pharma’s ₹4,326 crore IPO to open next week on April 25 | The IPO will comprise an offer for sale (OFS) of over 4 crore equity shares by the company's promoters and existing shareholders.
This will be the seventh IPO to be listed on exchanges in 2023 amid an uncertain macro environment.
The shares... |
| 16.09.2022 | Mankind Pharma Files DHRP For Rs 5,500 Cr IPO | |
| 19.01.2022 | ₹50 crore in Series A from Mankind Pharma, others " data-reg="Dogsee Chew raises ₹50 crore in Series A from Mankind Pharma, others ">Dogsee Chew raises ₹50 crore in Series A from Man... | ₹50 crore in Series A from Mankind Pharma, others " data-reg="Dogsee Chew raises ₹50 crore in Series A from Mankind Pharma, others ">Dogsee Chew raises ₹50 crore in Series A from Mankind Pharma, others
Premium Dogsee Chew ... |
